Click here to get full coverage on Notable Tuesday Option Activity: CELC, FHN, VSTS - Nasdaq

Notable Tuesday Option Activity: CELC, FHN, VSTS  Nasdaq

Notable Tuesday Option Activity: CELC, FHN, VSTS - Nasdaq

Click here to get full coverage on Can CELC stock resist market sell offs - 2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com

Can CELC stock resist market sell offs - 2025 Geopolitical Influence & Weekly Top Performers Watchlists  newser.com

Can CELC stock resist market sell offs - 2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com

Click here to get full coverage on Celcuity (Nasdaq: CELC) completes FDA NDA for gedatolisib, cutting progression risk by 76% - Stock Titan

Celcuity (Nasdaq: CELC) completes FDA NDA for gedatolisib, cutting progression risk by 76%  Stock Titan

Celcuity (Nasdaq: CELC) completes FDA NDA for gedatolisib, cutting progression risk by 76% - Stock Titan

Click here to get full coverage on New Analyst Forecast: $CELC Given $115.0 Price Target - Quiver Quantitative

New Analyst Forecast: $CELC Given $115.0 Price Target  Quiver Quantitative

New Analyst Forecast: $CELC Given $115.0 Price Target - Quiver Quantitative

Click here to get full coverage on Celcuity (CELC): Evaluating Valuation Following Key Phase 3 Results and Regulatory Progress - simplywall.st

Celcuity (CELC): Evaluating Valuation Following Key Phase 3 Results and Regulatory Progress  simplywall.st

Celcuity (CELC): Evaluating Valuation Following Key Phase 3 Results and Regulatory Progress - simplywall.st

Click here to get full coverage on Celcuity dips as H.C. Wainwright downgrades to 'neutral' - TradingView

Celcuity dips as H.C. Wainwright downgrades to 'neutral'  TradingView

Celcuity dips as H.C. Wainwright downgrades to 'neutral' - TradingView

Click here to get full coverage on Can CELC stock resist market sell offs - Weekly Trade Analysis & Real-Time Sentiment Analysis - newser.com

Can CELC stock resist market sell offs - Weekly Trade Analysis & Real-Time Sentiment Analysis  newser.com

Can CELC stock resist market sell offs - Weekly Trade Analysis & Real-Time Sentiment Analysis - newser.com

Click here to get full coverage on Liquidity Mapping Around (CELC) Price Events - news.stocktradersdaily.com

Liquidity Mapping Around (CELC) Price Events  news.stocktradersdaily.com

Liquidity Mapping Around (CELC) Price Events - news.stocktradersdaily.com

Click here to get full coverage on Celcuity (CELC) Price Target Increased by 16.06% to 97.66 - Nasdaq

Celcuity (CELC) Price Target Increased by 16.06% to 97.66  Nasdaq

Celcuity (CELC) Price Target Increased by 16.06% to 97.66 - Nasdaq

Click here to get full coverage on Can CELC stock resist market sell offs - CPI Data & Free Daily Entry Point Trade Alerts - newser.com

Can CELC stock resist market sell offs - CPI Data & Free Daily Entry Point Trade Alerts  newser.com

Can CELC stock resist market sell offs - CPI Data & Free Daily Entry Point Trade Alerts - newser.com

Click here to get full coverage on Stifel Maintains Celcuity (CELC) Buy Recommendation - Nasdaq

Stifel Maintains Celcuity (CELC) Buy Recommendation  Nasdaq

Stifel Maintains Celcuity (CELC) Buy Recommendation - Nasdaq

Click here to get full coverage on Can CELC stock resist market sell offs - Weekly Profit Report & High Accuracy Swing Entry Alerts - newser.com

Can CELC stock resist market sell offs - Weekly Profit Report & High Accuracy Swing Entry Alerts  newser.com

Can CELC stock resist market sell offs - Weekly Profit Report & High Accuracy Swing Entry Alerts - newser.com

Click here to get full coverage on Can CELC stock resist market sell offs - July 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com

Can CELC stock resist market sell offs - July 2025 Macro Moves & Free Reliable Trade Execution Plans  newser.com

Can CELC stock resist market sell offs - July 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com

Click here to get full coverage on Will CELC stock gain from strong economy - Portfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com

Will CELC stock gain from strong economy - Portfolio Gains Summary & Daily Growth Stock Investment Tips  newser.com

Will CELC stock gain from strong economy - Portfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com

Click here to get full coverage on Will CELC stock deliver consistent dividends - Market Risk Summary & Risk Managed Investment Strategies - newser.com

Will CELC stock deliver consistent dividends - Market Risk Summary & Risk Managed Investment Strategies  newser.com

Will CELC stock deliver consistent dividends - Market Risk Summary & Risk Managed Investment Strategies - newser.com

Click here to get full coverage on Can CELC stock sustain free cash flow growth - 2025 Price Targets & AI Driven Stock Movement Reports - newser.com

Can CELC stock sustain free cash flow growth - 2025 Price Targets & AI Driven Stock Movement Reports  newser.com

Can CELC stock sustain free cash flow growth - 2025 Price Targets & AI Driven Stock Movement Reports - newser.com

Click here to get full coverage on What to expect from CELC in the next 30 days - Market Performance Report & Daily Market Momentum Tracking - newser.com

What to expect from CELC in the next 30 days - Market Performance Report & Daily Market Momentum Tracking  newser.com

What to expect from CELC in the next 30 days - Market Performance Report & Daily Market Momentum Tracking - newser.com

Click here to get full coverage on Will CELC stock go up soon - Trade Signal Summary & Free Fast Entry Momentum Trade Alerts - newser.com

Will CELC stock go up soon - Trade Signal Summary & Free Fast Entry Momentum Trade Alerts  newser.com

Will CELC stock go up soon - Trade Signal Summary & Free Fast Entry Momentum Trade Alerts - newser.com

Click here to get full coverage on Forecasting CELC price range with options data - Weekly Trading Summary & Pattern Based Trade Signal System - newser.com

Forecasting CELC price range with options data - Weekly Trading Summary & Pattern Based Trade Signal System  newser.com

Forecasting CELC price range with options data - Weekly Trading Summary & Pattern Based Trade Signal System - newser.com

Click here to get full coverage on Can CELC hit a new high this month - Inflation Watch & Reliable Intraday Trade Plans - newser.com

Can CELC hit a new high this month - Inflation Watch & Reliable Intraday Trade Plans  newser.com

Can CELC hit a new high this month - Inflation Watch & Reliable Intraday Trade Plans - newser.com

Click here to get full coverage on Celcuity (CELC) Is Up 15.9% After Positive Phase 3 Results and FDA Review – Has the Bull Case Changed? - simplywall.st

Celcuity (CELC) Is Up 15.9% After Positive Phase 3 Results and FDA Review – Has the Bull Case Changed?  simplywall.st

Celcuity (CELC) Is Up 15.9% After Positive Phase 3 Results and FDA Review – Has the Bull Case Changed? - simplywall.st

Click here to get full coverage on Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application - Benzinga

Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application  Benzinga

Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application - Benzinga

Click here to get full coverage on Assessing Celcuity (CELC): What a 71x Price-to-Book Ratio Says About Valuation - Yahoo Finance

Assessing Celcuity (CELC): What a 71x Price-to-Book Ratio Says About Valuation  Yahoo Finance

Assessing Celcuity (CELC): What a 71x Price-to-Book Ratio Says About Valuation - Yahoo Finance

Click here to get full coverage on LifeSci Capital Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $95 - 富途牛牛

LifeSci Capital Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $95  富途牛牛

LifeSci Capital Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $95 - 富途牛牛

Click here to get full coverage on Celcuity (CELC): Examining Valuation After a 437% Year-to-Date Share Price Surge - Yahoo Finance

Celcuity (CELC): Examining Valuation After a 437% Year-to-Date Share Price Surge  Yahoo Finance

Celcuity (CELC): Examining Valuation After a 437% Year-to-Date Share Price Surge - Yahoo Finance

Click here to get full coverage on Celcuity Inc. (NASDAQ:CELC) Q3 2025 Earnings Call Transcript - Insider Monkey

Celcuity Inc. (NASDAQ:CELC) Q3 2025 Earnings Call Transcript  Insider Monkey

Celcuity Inc. (NASDAQ:CELC) Q3 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review - Yahoo Finance

Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review  Yahoo Finance

Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review - Yahoo Finance

Click here to get full coverage on Celcuity (CELC) Hits Fresh Record High on Stellar Breast Cancer Drug Trial Result - Yahoo Finance

Celcuity (CELC) Hits Fresh Record High on Stellar Breast Cancer Drug Trial Result  Yahoo Finance

Celcuity (CELC) Hits Fresh Record High on Stellar Breast Cancer Drug Trial Result - Yahoo Finance

Click here to get full coverage on Decoding Celcuity Inc (CELC): A Strategic SWOT Insight - GuruFocus

Decoding Celcuity Inc (CELC): A Strategic SWOT Insight  GuruFocus

Decoding Celcuity Inc (CELC): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on Market reaction to CELC’s recent news - Weekly Loss Report & High Conviction Trade Alerts - newser.com

Market reaction to CELC’s recent news - Weekly Loss Report & High Conviction Trade Alerts  newser.com

Market reaction to CELC’s recent news - Weekly Loss Report & High Conviction Trade Alerts - newser.com

Click here to get full coverage on Celcuity Inc Submits NDA for Gedatolisib to FDA - TradingView

Celcuity Inc Submits NDA for Gedatolisib to FDA  TradingView

Celcuity Inc Submits NDA for Gedatolisib to FDA - TradingView

Click here to get full coverage on Can CELC hit a new high this month - Quarterly Profit Report & Capital Efficiency Focused Strategies - newser.com

Can CELC hit a new high this month - Quarterly Profit Report & Capital Efficiency Focused Strategies  newser.com

Can CELC hit a new high this month - Quarterly Profit Report & Capital Efficiency Focused Strategies - newser.com

Click here to get full coverage on Celcuity Inc. Earnings Call: Strong Progress Amid Challenges - The Globe and Mail

Celcuity Inc. Earnings Call: Strong Progress Amid Challenges  The Globe and Mail

Celcuity Inc. Earnings Call: Strong Progress Amid Challenges - The Globe and Mail

Click here to get full coverage on A Look at Celcuity’s (CELC) Valuation Following Its Recent 50% Share Price Surge - Sahm

A Look at Celcuity’s (CELC) Valuation Following Its Recent 50% Share Price Surge  Sahm

A Look at Celcuity’s (CELC) Valuation Following Its Recent 50% Share Price Surge - Sahm

Click here to get full coverage on Celcuity (Nasdaq: CELC) to present at Stifel Healthcare Conference; webcast Nov 11 - Stock Titan

Celcuity (Nasdaq: CELC) to present at Stifel Healthcare Conference; webcast Nov 11  Stock Titan

Celcuity (Nasdaq: CELC) to present at Stifel Healthcare Conference; webcast Nov 11 - Stock Titan

Click here to get full coverage on $CELC stock is up 11% today. Here's what we see in our data. - Quiver Quantitative

$CELC stock is up 11% today. Here's what we see in our data.  Quiver Quantitative

$CELC stock is up 11% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on New Analyst Forecast: $CELC Given $70.0 Price Target | CELC Stock News - Quiver Quantitative

New Analyst Forecast: $CELC Given $70.0 Price Target | CELC Stock News  Quiver Quantitative

New Analyst Forecast: $CELC Given $70.0 Price Target | CELC Stock News - Quiver Quantitative

Click here to get full coverage on Celcuity (NASDAQ: CELC) plans Nov. 12 webcast at 4:30 p.m. ET for Third Quarter results - Stock Titan

Celcuity (NASDAQ: CELC) plans Nov. 12 webcast at 4:30 p.m. ET for Third Quarter results  Stock Titan

Celcuity (NASDAQ: CELC) plans Nov. 12 webcast at 4:30 p.m. ET for Third Quarter results - Stock Titan

Click here to get full coverage on What recovery options are there for CELC - Weekly Trend Report & Long-Term Growth Stock Strategies - newser.com

What recovery options are there for CELC - Weekly Trend Report & Long-Term Growth Stock Strategies  newser.com

What recovery options are there for CELC - Weekly Trend Report & Long-Term Growth Stock Strategies - newser.com

Click here to get full coverage on Can CELC stock sustain free cash flow growth - 2025 Short Interest & Capital Efficiency Focused Ideas - newser.com

Can CELC stock sustain free cash flow growth - 2025 Short Interest & Capital Efficiency Focused Ideas  newser.com

Can CELC stock sustain free cash flow growth - 2025 Short Interest & Capital Efficiency Focused Ideas - newser.com

Click here to get full coverage on Forecasting CELC price range with options data - Market Sentiment Report & Reliable Price Action Trade Plans - newser.com

Forecasting CELC price range with options data - Market Sentiment Report & Reliable Price Action Trade Plans  newser.com

Forecasting CELC price range with options data - Market Sentiment Report & Reliable Price Action Trade Plans - newser.com

Click here to get full coverage on Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating, Announces Target Price $108 - 富途牛牛

Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating, Announces Target Price $108  富途牛牛

Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating, Announces Target Price $108 - 富途牛牛

Click here to get full coverage on Can CELC hit a new high this month - Rate Cut & Weekly Breakout Watchlists - newser.com

Can CELC hit a new high this month - Rate Cut & Weekly Breakout Watchlists  newser.com

Can CELC hit a new high this month - Rate Cut & Weekly Breakout Watchlists - newser.com

Click here to get full coverage on New Analyst Forecast: $CELC Given $110.0 Price Target | CELC Stock News - Quiver Quantitative

New Analyst Forecast: $CELC Given $110.0 Price Target | CELC Stock News  Quiver Quantitative

New Analyst Forecast: $CELC Given $110.0 Price Target | CELC Stock News - Quiver Quantitative

Click here to get full coverage on Celcuity (CELC) Expands US$500 Million Credit Facility For Enhanced Financial Flexibility - Yahoo Finance

Celcuity (CELC) Expands US$500 Million Credit Facility For Enhanced Financial Flexibility  Yahoo Finance

Celcuity (CELC) Expands US$500 Million Credit Facility For Enhanced Financial Flexibility - Yahoo Finance

Click here to get full coverage on Earnings Flash (CELC) Celcuity Inc. Posts Q3 Adjusted Loss $0.78 per Share, vs. FactSet Est of $-0.96 - MarketScreener

Earnings Flash (CELC) Celcuity Inc. Posts Q3 Adjusted Loss $0.78 per Share, vs. FactSet Est of $-0.96  MarketScreener

Earnings Flash (CELC) Celcuity Inc. Posts Q3 Adjusted Loss $0.78 per Share, vs. FactSet Est of $-0.96 - MarketScreener

Click here to get full coverage on Celcuity Stock Surges on Positive Phase 3 Results and Analyst Upgrades - timothysykes.com

Celcuity Stock Surges on Positive Phase 3 Results and Analyst Upgrades  timothysykes.com

Celcuity Stock Surges on Positive Phase 3 Results and Analyst Upgrades - timothysykes.com

Click here to get full coverage on Celcuity Stock Surges on Positive Phase 3 Results for Breast Cancer Drug - StocksToTrade

Celcuity Stock Surges on Positive Phase 3 Results for Breast Cancer Drug  StocksToTrade

Celcuity Stock Surges on Positive Phase 3 Results for Breast Cancer Drug - StocksToTrade

Click here to get full coverage on 14.6‑month median PFS — Celcuity's PIK3CA mutant cohort fully enrolled; topline trial data due 2026 - Stock Titan

14.6‑month median PFS — Celcuity's PIK3CA mutant cohort fully enrolled; topline trial data due 2026  Stock Titan

14.6‑month median PFS — Celcuity's PIK3CA mutant cohort fully enrolled; topline trial data due 2026 - Stock Titan

Click here to get full coverage on $CELC stock is up 46% today. Here's what we see in our data. - Quiver Quantitative

$CELC stock is up 46% today. Here's what we see in our data.  Quiver Quantitative

$CELC stock is up 46% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on What technical charts say about CELC stock - Bear Alert & Expert Curated Trade Setups - newser.com

What technical charts say about CELC stock - Bear Alert & Expert Curated Trade Setups  newser.com

What technical charts say about CELC stock - Bear Alert & Expert Curated Trade Setups - newser.com

Click here to get full coverage on Celcuity (CELC) Skyrockets 167% on Breast Cancer Treatment Trial - Yahoo Finance

Celcuity (CELC) Skyrockets 167% on Breast Cancer Treatment Trial  Yahoo Finance

Celcuity (CELC) Skyrockets 167% on Breast Cancer Treatment Trial - Yahoo Finance

Click here to get full coverage on Wolfe Research initiates coverage on Celcuity stock with Outperform rating - Investing.com

Wolfe Research initiates coverage on Celcuity stock with Outperform rating  Investing.com

Wolfe Research initiates coverage on Celcuity stock with Outperform rating - Investing.com

Click here to get full coverage on $CELC stock is up 7% today. Here's what we see in our data. - Quiver Quantitative

$CELC stock is up 7% today. Here's what we see in our data.  Quiver Quantitative

$CELC stock is up 7% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Celcuity: What’s Happening With CELC Stock? - Forbes

Celcuity: What’s Happening With CELC Stock?  Forbes

Celcuity: What’s Happening With CELC Stock? - Forbes

Click here to get full coverage on $CELC stock is down 8% today. Here's what we see in our data. - Quiver Quantitative

$CELC stock is down 8% today. Here's what we see in our data.  Quiver Quantitative

$CELC stock is down 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on A Look at Celcuity (CELC) Valuation Following Phase 3 Breast Cancer and Prostate Cancer Trial Results - Sahm

A Look at Celcuity (CELC) Valuation Following Phase 3 Breast Cancer and Prostate Cancer Trial Results  Sahm

A Look at Celcuity (CELC) Valuation Following Phase 3 Breast Cancer and Prostate Cancer Trial Results - Sahm

Click here to get full coverage on Top 1% Celcuity Stock Shoots To Record High On Roche-Rivaling Breast Cancer Results - Investor's Business Daily

Top 1% Celcuity Stock Shoots To Record High On Roche-Rivaling Breast Cancer Results  Investor's Business Daily

Top 1% Celcuity Stock Shoots To Record High On Roche-Rivaling Breast Cancer Results - Investor's Business Daily

Click here to get full coverage on Guggenheim Initiates Coverage of Celcuity (CELC) with Buy Recommendation - Nasdaq

Guggenheim Initiates Coverage of Celcuity (CELC) with Buy Recommendation  Nasdaq

Guggenheim Initiates Coverage of Celcuity (CELC) with Buy Recommendation - Nasdaq

Click here to get full coverage on Celcuity: Blink And You Missed It (NASDAQ:CELC) - Seeking Alpha

Celcuity: Blink And You Missed It (NASDAQ:CELC)  Seeking Alpha

Celcuity: Blink And You Missed It (NASDAQ:CELC) - Seeking Alpha

Click here to get full coverage on Celcuity soars on phase 3 data for gedatolisib in breast cancer (CELC:NASDAQ) - Seeking Alpha

Celcuity soars on phase 3 data for gedatolisib in breast cancer (CELC:NASDAQ)  Seeking Alpha

Celcuity soars on phase 3 data for gedatolisib in breast cancer (CELC:NASDAQ) - Seeking Alpha

Click here to get full coverage on Will CELC stock go up soon - 2025 Risk Factors & Low Risk High Reward Ideas - newser.com

Will CELC stock go up soon - 2025 Risk Factors & Low Risk High Reward Ideas  newser.com

Will CELC stock go up soon - 2025 Risk Factors & Low Risk High Reward Ideas - newser.com

Click here to get full coverage on Celcuity’s Stock Soars with Promising Phase 3 Results - timothysykes.com

Celcuity’s Stock Soars with Promising Phase 3 Results  timothysykes.com

Celcuity’s Stock Soars with Promising Phase 3 Results - timothysykes.com

Click here to get full coverage on Celcuity Submits NDA for Gedatolisib to FDA - TipRanks

Celcuity Submits NDA for Gedatolisib to FDA  TipRanks

Celcuity Submits NDA for Gedatolisib to FDA - TipRanks

Click here to get full coverage on Celcuity (CELC) Q2 2025 Earnings Call Transcript - The Motley Fool

Celcuity (CELC) Q2 2025 Earnings Call Transcript  The Motley Fool

Celcuity (CELC) Q2 2025 Earnings Call Transcript - The Motley Fool

Click here to get full coverage on $500 Million Financing: Celcuity Boosts Credit Facility to Support FDA Filing for Cancer Drug Gedatolisib - Stock Titan

$500 Million Financing: Celcuity Boosts Credit Facility to Support FDA Filing for Cancer Drug Gedatolisib  Stock Titan

$500 Million Financing: Celcuity Boosts Credit Facility to Support FDA Filing for Cancer Drug Gedatolisib - Stock Titan

Click here to get full coverage on 7.3‑month PFS gain — Celcuity's gedatolisib triplet cuts progression/death risk 76% in Phase 3 - Stock Titan

7.3‑month PFS gain — Celcuity's gedatolisib triplet cuts progression/death risk 76% in Phase 3  Stock Titan

CELC

Price Chart

Key Statistics

Technicals

About CELC

Latest News

Notable Tuesday Option Activity: CELC, FHN, VSTS - Nasdaq

Can CELC stock resist market sell offs - 2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com

Celcuity (Nasdaq: CELC) completes FDA NDA for gedatolisib, cutting progression risk by 76% - Stock Titan

Advanced Charts

Top Gainers

Top Losers